1. Home
  2. ONMD vs SLGL Comparison

ONMD vs SLGL Comparison

Compare ONMD & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.65

Market Cap

42.1M

Sector

N/A

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$65.94

Market Cap

254.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
SLGL
Founded
2006
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.1M
254.1M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
ONMD
SLGL
Price
$0.65
$65.94
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$110.00
AVG Volume (30 Days)
257.6K
54.6K
Earning Date
05-13-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
83.33
N/A
EPS
N/A
N/A
Revenue
$1,359,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$223.84
P/E Ratio
N/A
N/A
Revenue Growth
111.35
N/A
52 Week Low
$0.49
$23.15
52 Week High
$4.22
$97.97

Technical Indicators

Market Signals
Indicator
ONMD
SLGL
Relative Strength Index (RSI) 54.00 35.12
Support Level $0.58 $64.78
Resistance Level $0.79 $67.85
Average True Range (ATR) 0.04 4.31
MACD 0.01 -0.76
Stochastic Oscillator 74.10 4.29

Price Performance

Historical Comparison
ONMD
SLGL

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: